logologo
Search
Ctrl+K
arrow
ToolBar Logo

Laxmi Dental Shines in Q2 FY26 with Robust Sales and Digital Push

Laxmi Dental Limited, a prominent player in India's integrated dental products sector, has reported a stellar performance for the second quarter and first half of the financial year 2026. The company achieved its strongest ever quarterly sales for the second consecutive time in Q2 FY26, underscoring its resilient business model and effective strategic approach amidst a dynamic global economic landscape. Consolidated revenue from operations for Q2 FY26 surged by 26.5% year-on-year to Rs. 72.27 crore, while for H1 FY26, it grew by 18.1% to Rs. 137.9 crore. Despite global uncertainties, the company maintained a healthy EBITDA margin of 15.3% in Q2 FY26 and 16.6% for H1 FY26, with PAT margins at 11.8% and 12.2% respectively. This robust performance reflects Laxmi Dental's deep industry expertise and commitment to operational excellence.

The growth was broad-based across key segments. The dental lab business, excluding scanner sales, grew by a solid 29.9% year-on-year, driven by strong traction in both domestic and international markets. Domestic lab business expanded by 23.2% to Rs. 22.5 crore, largely enabled by scanner adoption in previous quarters. The international lab business outpaced domestic growth with a 39.2% year-on-year increase, reaching Rs. 18.5 crore, fueled by new customers and geographical expansion despite tariff uncertainties in the US. The aligner solutions segment also saw significant growth, with revenues rising by 12.3% year-on-year to Rs. 20 crore. Within this, the 'Taglus' brand, which produces raw materials and machines for aligner manufacturing, recorded an impressive 29.9% year-on-year growth, showcasing the superior quality and global demand for its materials. The clear aligner business, 'Bizdent', maintained steady year-on-year numbers but saw a 10.9% quarter-on-quarter growth, navigating competitive pressures. Kids-E-Dental, the pediatric dental products segment, showed signs of recovery with a 21.4% quarter-on-quarter growth, with accelerated momentum anticipated post-regulatory clearances for international geographies.

Financial Highlights (INR Crore)Q2 FY26H1 FY26Q2 FY25H1 FY25
Revenue from Operations72.27137.957.12116.78
Gross Profit49.5397.6143.2588.52
EBITDA11.0222.938.7322.73
PAT after JVs8.5316.865.9022.74
EBITDA Margin (%)15.316.615.319.5
PAT Margin (%)11.812.210.319.5

Strategic Thrust: Digital Transformation and Market Expansion

Laxmi Dental's strategic focus on digital dentistry and Artificial Intelligence (AI) is a cornerstone of its future growth. Scanner sales, a key indicator of this push, jumped by 94.7% year-on-year in Q2 FY26, with H1 FY26 sales already surpassing the total units sold in the entire FY25. These scanner sales are strategic, driving digital transformation across the company's dental network and laying the foundation for future growth. The company is deeply committed to enhancing brand visibility, expanding its dental network, and leveraging emerging opportunities in the dynamic dental industry. Investments in automation, R&D, and brand building are ongoing, positioning Laxmi Dental to sustain its growth trajectory and deliver long-term value to stakeholders.

Management highlighted several key initiatives, including deepening penetration within the existing dental network while expanding to new geographies, scaling branded product offerings, undertaking product enhancements and launching new dental products like Teen Aligners and PEOT, enhancing manufacturing capacities with automation and new technologies, and continuing a multi-channel approach in marketing. The company's vertically integrated approach, from manufacturing raw materials like aligner sheets and 3D printing resins to branded scanners and pediatric crowns, provides a significant competitive advantage in quality, process efficiency, and cross-selling opportunities.

Segment Performance (INR Crore)Q2 FY26Q1 FY26Q2 FY25
Laboratory offerings40.938.631.5
Aligner Solutions20.018.517.8
Scanner Sales8.95.94.6

Outlook and Financial Health

Looking ahead, Laxmi Dental is confident in maintaining its strong growth trajectory and meeting its full-year revenue guidance of 20%-25% growth and 13%-15% PAT margin for FY26. The company's financial health is robust, marked by a significant decline in finance costs as it paid off the entire amount of debt from its books. Unutilized funds of Rs. 64 crore from the IPO proceeds are earmarked for future CAPEX, signaling continued investment in growth. While the company acknowledges competitive pressures in certain domestic markets and the impact of US tariffs on margins, it remains focused on operational efficiency and long-term value creation. The management's proactive approach to digital adoption, product innovation, and market expansion positions Laxmi Dental as a key player poised for sustained success in the evolving global dental industry.

Frequently Asked Questions

Laxmi Dental reported its strongest ever quarterly sales in Q2 FY26, with revenue growing 26.5% year-on-year to Rs. 72.27 crore. The company achieved an EBITDA margin of 15.3% and a PAT margin of 11.8% for the quarter.
The dental lab business grew 29.9% year-on-year, with both domestic and international markets showing strong traction. The aligner solutions segment grew 12.3% YoY, primarily driven by 'Taglus' (29.9% YoY growth). Kids-E-Dental showed a 21.4% QoQ growth.
Laxmi Dental is deeply committed to advancing digital dentistry. Scanner sales jumped 94.7% YoY in Q2 FY26, with H1 FY26 sales already exceeding total FY25 sales. These sales are strategic for driving digital transformation and increasing digital penetration among dentists.
Key growth drivers include growing awareness of oral healthcare, high prevalence of dental problems in India, technological advancements like 3D printing and CAD/CAM, the shift towards premium metal-free crowns, and rising disposable income.
Management is confident in achieving 20%-25% revenue growth and 13%-15% PAT margin for FY26. They expect scanner sales momentum to continue and gross margins to return to 75%-80% in the mid-to-long term.
Despite competitive pressures, the company is focusing on improving margins, expanding its product portfolio (e.g., Teen Aligners, PEOT), and increasing penetration among various types of dentists (orthodontists, general, pediatric) rather than aggressive discounting.
Laxmi Dental has paid off its entire debt, significantly reducing finance costs. The company has Rs. 64 crore of unutilized IPO proceeds that will be deployed for CAPEX over a period of time, indicating future investment in growth.

Content

  • Laxmi Dental Shines in Q2 FY26 with Robust Sales and Digital Push
  • Strategic Thrust: Digital Transformation and Market Expansion
  • Outlook and Financial Health
  • Frequently Asked Questions